<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Prophylactic antibiotics for preventing gram‐positive infections associated with long‐term central venous catheters in adults and children receiving treatment for cancer - van den Bosch, CH - 2021 | Cochrane Library</title> <meta content="Prophylactic antibiotics for preventing gram‐positive infections associated with long‐term central venous catheters in adults and children receiving treatment for cancer - van den Bosch, CH - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003295.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Prophylactic antibiotics for preventing gram‐positive infections associated with long‐term central venous catheters in adults and children receiving treatment for cancer - van den Bosch, CH - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003295.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003295.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Prophylactic antibiotics for preventing gram‐positive infections associated with long‐term central venous catheters in adults and children receiving treatment for cancer" name="citation_title"/> <meta content="Ceder H van den Bosch" name="citation_author"/> <meta content="Princess Máxima Center for Pediatric Oncology" name="citation_author_institution"/> <meta content="Job van Woensel" name="citation_author"/> <meta content="Emma Children's Hospital / Academic Medical Centre" name="citation_author_institution"/> <meta content="Marianne D van de Wetering" name="citation_author"/> <meta content="Princess Máxima Center for Pediatric Oncology" name="citation_author_institution"/> <meta content="m.d.vandewetering-4@prinsesmaximacentrum.nl" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD003295.pub4" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/10/07" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003295.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003295.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003295.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Bacterial Agents [therapeutic use]; *Catheter-Related Infections [prevention &amp; control]; *Central Venous Catheters [adverse effects]; Heparin; *Neoplasms [complications, drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003295.pub4&amp;doi=10.1002/14651858.CD003295.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="VXKc2U6b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003295\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003295\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","th","ko","ms","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003295.pub4",title:"Prophylactic antibiotics for preventing gram\\u2010positive infections associated with long\\u2010term central venous catheters in adults and children receiving treatment for cancer",firstPublishedDate:"Oct 7, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=VXKc2U6b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003295.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003295.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003295.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003295.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003295.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003295.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003295.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003295.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003295.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003295.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3502 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003295.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-sec-0062"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-sec-0056"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/appendices#CD003295-sec-0067"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/supinfo/CD003295StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/supinfo/CD003295StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Prophylactic antibiotics for preventing gram‐positive infections associated with long‐term central venous catheters in adults and children receiving treatment for cancer </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information#CD003295-cr-0004">Ceder H van den Bosch</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information#CD003295-cr-0005">Job van Woensel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information#CD003295-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Marianne D van de Wetering</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information/en#CD003295-sec-0074">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 07 October 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003295.pub4">https://doi.org/10.1002/14651858.CD003295.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003295-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003295-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003295-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003295-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003295-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD003295-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD003295-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003295-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003295-abs-0001" lang="en"> <section id="CD003295-sec-0001"> <h3 class="title" id="CD003295-sec-0001">Background</h3> <p>This is an updated version of a Cochrane Review last published in 2013. Long‐term central venous catheters (CVCs), including tunnelled CVCs (TCVCs) and totally implanted devices or ports (TIDs), are increasingly used when treating people with cancer. Despite international guidelines on sterile insertion and appropriate CVC maintenance and use, infections remain a common complication. These infections are mainly caused by gram‐positive bacteria. Antimicrobial prevention strategies aimed at these micro‐organisms could potentially decrease the majority of CVC‐related infections. The aim of this review was to evaluate the efficacy of prophylactic antibiotics for the prevention of gram‐positive infections in people with cancer who have long‐term CVCs. </p> </section> <section id="CD003295-sec-0002"> <h3 class="title" id="CD003295-sec-0002">Objectives</h3> <p>To assess the effects of administering antibiotics prior to the insertion of long‐term CVCs or as a flush/lock solution, or both during long‐term CVC access to prevent gram‐positive CVC‐related infections in adults and children receiving treatment for cancer. </p> </section> <section id="CD003295-sec-0003"> <h3 class="title" id="CD003295-sec-0003">Search methods</h3> <p>The search for this updated review was conducted on 19 November 2020. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, MEDLINE via Ovid and Embase via Ovid. We searched ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform portal for additional articles. </p> </section> <section id="CD003295-sec-0004"> <h3 class="title" id="CD003295-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that compared either the administration of prophylactic antibiotics prior to long‐term CVC insertion versus no administration of antibiotics, or the use of an antibiotic versus a non‐antibiotic flush/lock solution in long‐term CVCs, in adults and children receiving treatment for cancer. </p> </section> <section id="CD003295-sec-0005"> <h3 class="title" id="CD003295-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. Two authors independently selected studies, classified them and extracted data onto a predesigned data collection form. The outcomes of interest were gram‐positive catheter‐related infection events and total number of CVCs and CVC days. We pooled the data using a random‐effects model for meta‐analyses. We used the GRADE approach to assess the certainty of the evidence.  </p> </section> <section id="CD003295-sec-0006"> <h3 class="title" id="CD003295-sec-0006">Main results</h3> <p>For this update, we identified 310 potentially relevant studies and screened them for eligibility. We included one additional RCT with 404 participants. The original review included 11 RCTs with a total of 840 people with cancer (adults and children). In total this review included 12 RCTs with 1244 participants. </p> <p><b>Antibiotics prior to insertion of the CVC</b> <br/>Six trials compared the use of antibiotics (vancomycin, teicoplanin, ceftazidime or cefazolin) versus no antibiotics given before the insertion of a long‐term CVC. One study did not observe any CVC‐related infection events in either group was not included in the quantitative analysis as it was not possible to calculate a risk ratio. Administering an antibiotic prior to insertion of the CVC may not reduce gram‐positive CVC‐related infections (pooled risk ratio 0.67, confidence interval (CI) 95% 0.32 to 1.43; control versus intervention group risk 10.4% versus 7.3% of the participants; 5 studies, 648 participants; moderate‐certainty evidence). We sought adverse event data, but these were not described by the authors. The overall risk of bias was deemed low. <b> </b> </p> <p><b>Antibiotics as a flushing or locking solution</b><br/>Six trials compared a combined antibiotic (vancomycin, amikacin or taurolidine) and heparin solution with a heparin‐only solution for flushing or locking the long‐term CVC after use. One study did not observe any CVC‐related sepsis events (CRS) and was not included in this study in the quantitative analysis as it was not possible to calculate a risk ratio. Flushing and locking long‐term CVCs with a combined antibiotic and heparin solution likely reduced the risk of gram‐positive CVC‐related infections compared to a heparin‐only solution (pooled rate ratio 0.47, CI 95% 0.26 to 0.85; control versus intervention group rate ratio 0.66 versus 0.27 per 1000 CVC‐days; 5 studies, 443 participants; moderate‐certainty evidence). One trial reported a higher incidence of occlusions and participants in one trial reported an unpleasant taste after flushing associated with a combined antibiotic and heparin solution. The overall risk of bias was deemed low.  </p> </section> <section id="CD003295-sec-0007"> <h3 class="title" id="CD003295-sec-0007">Authors' conclusions</h3> <p>Since the last version of this review, we included one additional study. There was no observed benefit of administering antibiotics before the insertion of long‐term CVCs to prevent gram‐positive CVC‐related infections. Flushing or locking long‐term CVCs with an antibiotic solution likely reduces gram‐positive CVC‐related infections experienced in people at risk of neutropenia through chemotherapy or disease. However, a limitation of this review is heterogeneity between the studies for both outcomes. Insufficient data were available to evaluate if the conclusions apply equally for different CVC types and for adults versus children. It must be noted that the use of an antibiotic flush/lock solution may increase microbial antibiotic resistance, therefore it should be reserved for high‐risk people or if the baseline CVC‐related infection rates are high. Further research is needed to identify high‐risk groups most likely to benefit from these antibiotic flush/lock solutions.  </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003295-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003295-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003295-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003295-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003295-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD003295-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003295-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD003295-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD003295-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003295-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD003295-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003295-abs-0002" lang="en"> <h3>Prophylactic antibiotics for preventing gram‐positive infections associated with long‐term central venous catheters in adults and children receiving treatment for cancer </h3> <p><b>The issue</b><br/>People undergoing anti‐cancer treatment (chemotherapy) often have a catheter (tube) inserted into a large vein, through which their chemotherapy is given. This is known as a central venous catheter (CVC). As chemotherapy is usually administered over several months to years, long‐term CVCs are used. Despite sterile insertion and care afterwards, these CVCs often become infected by a type of bacteria called gram‐positive bacteria. Giving antibiotics as a preventive (prophylactic antibiotics) before the catheter is inserted, or using the antibiotics as a lock or flush solution, or both, may prevent these infections. A lock/flush solution is instilled in the catheter when it is not in use. This solution often contains heparin, saline, or both, to prevent a clot forming in the catheter.  </p> <p><b>The aim of the review</b><br/>The aim of this review was to determine whether giving antibiotics before catheter insertion or as a lock/flush solution can prevent gram‐positive CVC‐related infections. </p> <p><b>What are the main findings?</b><br/>We searched databases to identify randomised controlled trials (RCTs ‐ clinical studies where people are randomly put into one of two or more treatment groups). We identified 12 relevant studies, which included a total of 1244 adults and children with cancer. </p> <p>We included six studies (756 people) that compared giving antibiotics before the insertion of the CVC against not giving antibiotics. We found that giving an antibiotic before CVC insertion did not prevent infections. The studies authors' did not describe side‐effects.  </p> <p>We included six studies (488 people) that compared an antibiotic solution with a heparin‐only solution to flush/lock a CVC. We found that an antibiotic lock/flush solution reduced the number of CVC‐related infections. People in one study reported an unpleasant taste after flushing, and one study found there were fewer CVC obstructions (e.g. a clot) in people who received the combined antibiotic and anticoagulant solution.  </p> <p><b>Certainty of the evidence</b><br/>We have moderate confidence in the evidence for giving antibiotics prior to CVC insertion and antibiotic lock/flush solutions since the studies were done in different people, used different types of catheters and antibiotics, and measured their results in different ways.  </p> <p><b>What are the conclusions?</b><br/>We did not observe any benefit of giving antibiotics before the insertion of long‐term CVCs to prevent gram‐positive CVC‐related infections. Flushing/locking long‐term CVCs with an antibiotic appeared to reduce gram‐positive CVC‐related infections in people with cancer. It must be noted that the use of an antibiotic flush/lock solution may increase microbial antibiotic resistance, therefore it should be reserved for high‐risk people or if baseline CVC‐related infection rates are high.  </p> <p>This review updates our previous review. The evidence is up to date to 19 November 2020. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003295-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003295-sec-0062"></div> <h3 class="title" id="CD003295-sec-0063">Implications for practice</h3> <section id="CD003295-sec-0063"> <p>Since the last version of this review, we have included one additional study. Flushing or locking long‐term central venous catheters (CVCs) with an antibiotic solution appears to reduce gram‐positive CVC‐related infections experienced in people at risk of neutropenia through chemotherapy or disease. Due to insufficient data it is not clear whether this applies equally to tunnelled CVCs and totally implantable devices, or equally to adults and children. The use of an antibiotic and heparin flush/lock solution may be of value in people who are at high risk and where baseline CVC infection rates are high. However, routine antibiotic administration, irrespective of risk, is likely to increase microbial resistance. </p> </section> <h3 class="title" id="CD003295-sec-0064">Implications for research</h3> <section id="CD003295-sec-0064"> <p>Although some of the included studies stratified risk groups (for example, neutropenic and non‐neutropenic), none analysed these separately due to insufficient numbers. A large randomised controlled trial to investigate the role of prophylactic antibiotic lock solutions and to identify high‐risk groups that are most likely to benefit from antibiotic prophylaxis is needed.  </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003295-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003295-sec-0008"></div> <div class="table" id="CD003295-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Prophylactic antibiotics for the prevention of gram‐positive infections associated with long‐term central venous children receiving treatment for cancer </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults and children diagnosed with an oncologic disease with a newly‐inserted long‐term CVC who were at risk of neutropenia due to chemotherapy or disease<br/><b>Setting:</b> inpatient and outpatient<br/><b>Intervention:</b> prophylactic antibiotics (prior to long‐term CVC insertion or as lock/flush solutions)<br/><b>Comparison:</b> no antibiotic administration </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk control groups</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Absolute effect prophylactic antibiotics (95% CI)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Antibiotics prior to long‐term CVC insertion versus control: catheter‐related infections</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk ratio 0.67<br/>(0.32 to 1.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>648 (5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Data inconsistent across studies; I² = 55%; P = 0.30.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000 participants</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000 (30 to 164)<br/> participants  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Antibiotic versus heparin only lock/flush solution: catheter‐related infections</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rate ratio 0.47 (0.26 to 0.85)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>443<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Data consistent across included studies; I² = 0%; P = 0.01.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.66 per 1000 CVC‐days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.27 per 1000 (0.16 to 0.43) CVC‐days</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antibiotic versus heparin only lock/flush solution: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300 (3 RCTs)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An unpleasant taste was described by the majority of the participants included in the taurolidine/citrate group by one study. One study reported a significant lower incidence of occlusions associated with the vancomycin/ciprofloxacin/heparin group compared to the heparin‐only group. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the assumed risk is the mean control group risk across studies. The absolute effect (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>CVC: c</b>entral venous catheter </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence by one level due to substantial heterogeneity between the sutdies ( I<sup>2</sup> &gt; 50% and confidence intervals were not overlapping).  </p> <p><sup>b</sup>We downgraded the evidence since the sample was clinically heterogeneous.  </p> <p><sup>c</sup>We downgraded the evidence due to imprecision since only a few studies described the incidence of adverse events.  </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003295-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003295-sec-0009"></div> <section id="CD003295-sec-0010"> <h3 class="title" id="CD003295-sec-0010">Description of the condition</h3> <p>This review is an update of a Cochrane Review last published in 2013 (<a href="./references#CD003295-bbs2-0074" title="vande Wetering MD ,  van WoenselJB , LawrieTA . Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. Cochrane Database of Systematic Reviews2013, Issue 11. Art. No: CD003295. [DOI: 10.1002/14651858.CD003295.pub3]">van de Wetering 2013</a>). </p> <p>People undergoing treatment for cancer need adequate venous access because of the frequent blood draws and administration of chemotherapy, intravenous fluids, blood products and other medications. To limit the discomfort of short‐term venous access, long‐term central venous catheters (CVCs), including tunnelled central venous catheters (TCVCs) and totally implanted devices or ports (TIDs), are used in more than two thirds of the children and adults undergoing chemotherapy (<a href="./references#CD003295-bbs2-0046" title="GroegerJS , LucasAB , CoitD , LaQuagliaM , BrownAE , Turnbull A et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunnelled chronic venous access catheter infections in cancer patients. Annals of Surgery1993;91:3.">Groeger 1993</a>; <a href="./references#CD003295-bbs2-0050" title="IngramJ , WeitzmanS , GreenbergML , ParkinP , FillerR . Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external catheters and subcutaneous ports. American Journal of Pediatric Hematology and Oncology1991;13:130-6.">Ingram 1991</a>; <a href="./references#CD003295-bbs2-0068" title="SimonA , BodeU , BeutelK . Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clinical Microbiology and Infection2006;12:606-20.">Simon 2006</a>). However, the use of long‐term CVCs is limited by the risk of blood clot formation and infection. The risk of CVC‐related infections ranges from 1.4 infections per 1000 catheter days (<a href="./references#CD003295-bbs2-0040" title="Bagnall-ReebH . Evidence for the use of the antibiotic lock technique. Journal of Infusion Nursing2004;27(2):118-22.">Bagnall‐Reeb 2004</a>; <a href="./references#CD003295-bbs2-0059" title="PressOW , RamseyPG , LarsonEB . Hickman catheter infections in patients with malignancies. Medicine1984;63:189.">Press 1984</a>; <a href="./references#CD003295-bbs2-0064" title="SchinabeckMK , GhannoumMA . Catheter related infections-diagnosis treatment and prevention. Clinical Microbiology Newsletter2003;25(15):113-9.">Schinabeck 2003</a>) to 2.2 infections per 1000 catheter days (<a href="./references#CD003295-bbs2-0046" title="GroegerJS , LucasAB , CoitD , LaQuagliaM , BrownAE , Turnbull A et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunnelled chronic venous access catheter infections in cancer patients. Annals of Surgery1993;91:3.">Groeger 1993</a>; <a href="./references#CD003295-bbs2-0062" title="SarperN , ZenginE , CorapciogluF , TugayM . Totally implantable central venous access devices in children with hemato oncologic malignancies: Evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices. Pediatric Hematology and Oncology2006;23:459-70.">Sarper 2006</a>). The duration of antimicrobial therapy to treat these infections mostly ranges from seven to 21 days. Success rates of 60% to 91% are reported, although often the device has to be removed (<a href="./references#CD003295-bbs2-0040" title="Bagnall-ReebH . Evidence for the use of the antibiotic lock technique. Journal of Infusion Nursing2004;27(2):118-22.">Bagnall‐Reeb 2004</a>). Approximately one third of all people with cancer experience an episode of infection while having a long‐term CVC in place. Seventy per cent of the organisms that are cultured are gram‐positive organisms, mainly coagulase‐negative staphylococci, <i>Staphylococcus aureus</i> and enterococci<i>.</i> Other organisms include gram‐negative organisms (15%), mainly <i>Escherichia coli</i> , fungal organisms (8%) (for example <i>Candida</i> species) and anaerobic organisms (7%) (<a href="./references#CD003295-bbs2-0058" title="O'GradyNP , AlexanderM , DellingerEP , GerberdingJL , HeardSO , Maki DG et al. Guidelines for the prevention of intravascular catheter related infections. Pediatrics2002;110:51-75.">O'Grady 2002</a>). </p> <p>The adherence to and colonisation of CVCs with micro‐organisms is facilitated by the formation of a very thin biofilm inside the catheter lumen. This process is influenced by several factors, such as the production of fibro glycocalyx (extracellular slime) by bacteria. In addition, the host reaction to the CVC results in the formation of a thrombin sleeve rich in clotting factors such as fibronectin, fibrinogen and fibrin, which contributes to the formation of the biofilm (<a href="./references#CD003295-bbs2-0040" title="Bagnall-ReebH . Evidence for the use of the antibiotic lock technique. Journal of Infusion Nursing2004;27(2):118-22.">Bagnall‐Reeb 2004</a>; <a href="./references#CD003295-bbs2-0043" title="DarouicheRO . Prevention of vascular catheter related infections. The Netherlands Journal of Medicine1999;55:92-9.">Darouiche 1999</a>). This means that adequate antibiotic treatment may only lead to the resolution of the CVC infection in certain cases (e.g. infections caused by less pathogenic coagulase‐negative staphylococci), whereas in other cases (e.g. infections caused by <i>Pseudomonas</i> , <i>S aureus</i> or fungi) this will be much more difficult, leading to removal of the CVC (<a href="./references#CD003295-bbs2-0068" title="SimonA , BodeU , BeutelK . Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clinical Microbiology and Infection2006;12:606-20.">Simon 2006</a>). </p> <p>The organisms responsible for CVC colonisations and infections come from different sources. These are: the skin, the catheter hub, the CVC prior to insertion, hematogenous seeding (infections originating outside the catheter can reach the CVC via the bloodstream) and contamination of the intravenous fluids given to the person (e.g. intravenous total parenteral nutrition) (<a href="./references#CD003295-bbs2-0047" title="HachemR , RaadI . Prevention and management of longterm catheter related infections in cancer patients. Cancer Investigation2002;20(7 and 8):1105-13.">Hachem 2002</a>). Early CVC‐related infections (infections that develop within 45 days after placement of the catheter) are mostly caused by organisms from the skin insertion site. This is the time period during which many manipulations of the CVC are necessary due to the intensity of the chemotherapy. After 45 days, the catheter hub becomes a far more important source of infection (<a href="./references#CD003295-bbs2-0039" title="AbbasAA , FryerCJ , PaltielC , ChedidF , FelimbanSK , YousefAA , et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatric Blood and Cancer2004;42:325-31.">Abbas 2004</a>; <a href="./references#CD003295-bbs2-0067" title="ShaulDB , ScheerB , RokhsarS , JonesVA , ChanLS , BoodyBA , et al. Risk factors for early infection of central venous catheters in pediatric patients. Journal of the American College of Surgeons1998;186(6):654-8.">Shaul 1998</a>). International guidelines have been developed to prevent CVC‐related infections (<a href="./references#CD003295-bbs2-0042" title="Hospital Infection Control Practices Advisory Committee. Recommendations for the prevention of nosocomial intravascular device related infections. American Journal of Infection Control1990;24(4):277-93.">CPAC 1990</a>; <a href="./references#CD003295-bbs2-0058" title="O'GradyNP , AlexanderM , DellingerEP , GerberdingJL , HeardSO , Maki DG et al. Guidelines for the prevention of intravascular catheter related infections. Pediatrics2002;110:51-75.">O'Grady 2002</a>). These include guidelines for CVC insertion, maintenance and care. The clinical care management bundle published by <a href="./references#CD003295-bbs2-0063" title="SchifferCA , ManguPB , WadeJC , Camp-SorrelD , CopeDG , El-Rayes BF et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology2013;31(10):1357-70.">Schiffer 2013</a> (including hand hygiene, barrier precautions for insertion, chlorhexidine skin antisepsis, optimal catheter site selection and assessment of CVC necessity) sets the standard for CVC care. </p> </section> <section id="CD003295-sec-0011"> <h3 class="title" id="CD003295-sec-0011">Description of the intervention</h3> <p>Systemic antibiotics may be given intravenously before the insertion of the CVC in an attempt to reduce early infections; however, in the original versions of this review we found no evidence to support the use of prophylactic antibiotics in this way (<a href="./references#CD003295-bbs2-0073" title="vande WeteringMD , vanWoenselJB . Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database of Systematic Reviews2007, Issue Issue 1. Art. No.: CD003295. Art. No: CD003295. [DOI: 10.1002/14651858.CD003295.pub2]">van de Wetering 2007</a>; <a href="./references#CD003295-bbs2-0074" title="vande Wetering MD ,  van WoenselJB , LawrieTA . Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. Cochrane Database of Systematic Reviews2013, Issue 11. Art. No: CD003295. [DOI: 10.1002/14651858.CD003295.pub3]">van de Wetering 2013</a>). </p> <p>Standard maintenance of long‐term CVCs includes flushing the CVC with saline after usage and closing the CVC with a lock solution to remain in the CVC until the next use. There are conflicting data about the relative value of adding prophylactic heparin to saline lock solutions (<a href="./references#CD003295-bbs2-0053" title="López‐Briz E, Ruiz GarciaV , Cabello JB, Bort‐Martí S, Carbonell Sanchis R, BurlsA . Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 30 July 2018, Issue 7. Art. No: CD008462. [DOI: 10.1002/14651858.CD008462.pub3]">López‐Briz 2018</a>; <a href="./references#CD003295-bbs2-0063" title="SchifferCA , ManguPB , WadeJC , Camp-SorrelD , CopeDG , El-Rayes BF et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology2013;31(10):1357-70.">Schiffer 2013</a>); however, heparinised saline is still commonly used. Adding an antibiotic to the flush solution may prevent biofilm formation and eliminate bacteria introduced into the CVC via the skin or during CVC access, from any source. Antibiotics that have activity against gram‐positive organisms and which have been evaluated for this purpose include vancomycin, taurolidine, teicoplanin and minocycline. </p> </section> <section id="CD003295-sec-0012"> <h3 class="title" id="CD003295-sec-0012">How the intervention might work</h3> <p>People with cancer are at an increased risk of infections due to the immunosuppressive effects of chemotherapy or their disease (e.g. haematological malignancies), or both. Administering prophylactic antibiotics may reduce the likelihood that gram‐positive bacteria, introduced at the time of CVC insertion or following access, will thrive and lead to a CVC‐related infection. </p> </section> <section id="CD003295-sec-0013"> <h3 class="title" id="CD003295-sec-0013">Why it is important to do this review</h3> <p>This review is an update of a Cochrane Review originally published in 2003 then updated in 2007 and 2013 (see <a href="./references#CD003295-bbs1-0005" title="">Other published versions of this review</a>), in which we found evidence of moderate‐certainty to support adding an antibiotic with activity against gram‐positive organisms to the standard flush or lock solution, and no evidence to support the use of systemic antibiotics prior to long‐term CVC insertion. There remains uncertainty as to whether antibiotic prophylaxis is of benefit to adults and children at a high risk of CVC‐related infections. By updating this review and incorporating new evidence, we hoped to clarify the role of prophylactic antibiotics to prevent gram‐positive infections in long‐term CVCs. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003295-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003295-sec-0014"></div> <p>To assess the effects of administering antibiotics prior to the insertion of long‐term CVCs or as a flush/lock solution, or both during long‐term CVC access to prevent gram‐positive CVC‐related infections in adults and children receiving treatment for cancer. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003295-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003295-sec-0015"></div> <section id="CD003295-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003295-sec-0017"> <h4 class="title">Types of studies</h4> <p> <ol id="CD003295-list-0001"> <li> <p>Randomised controlled trials (RCTs) that compare the administration of antibiotics to no administration of antibiotics prior to the insertion of long‐term central venous catheters (CVCs) to reduce gram‐positive infections related to the CVC. </p> </li> <li> <p>RCTs that compare an antibiotic flush/lock solution with a standard non‐antibiotic solution to reduce gram‐positive infections related to the CVC. </p> </li> <li> <p>RCTs that combine the first two comparisons.</p> </li> </ol> </p> </section> <section id="CD003295-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included trials in adults and children with newly inserted long‐term CVCs (tunnelled CVCs (TCVCs) or totally implantable devices (TIDs)) to facilitate chemotherapy. </p> </section> <section id="CD003295-sec-0019"> <h4 class="title">Types of interventions</h4> <p> <ol id="CD003295-list-0002"> <li> <p>Intravenous antibiotics for gram‐positive organisms, e.g. vancomycin, taurolidine, teicoplanin and minocycline, administered before long‐term CVC insertion. </p> </li> <li> <p>An antibiotic solution administered as a CVC flush/lock solution during long‐term CVC use.  </p> </li> </ol> </p> </section> <section id="CD003295-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We investigated the following gram‐positive CVC‐related infections and adverse events related to the interventions.  </p> <section id="CD003295-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>We defined CVC‐related infections as follows.</p> <p> <ul id="CD003295-list-0003"> <li> <p>CVC‐related sepsis (CRS). Many CRS definitions are used throughout the literature; most studies used the catheter‐related bloodstream infection (CRBSI) or central‐line associated bloodstream infection (CLABSI) definition (<a href="./references#CD003295-bbs2-0041" title="Centers for Disease Control and Prevention. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection). Available from: www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf2021.">CDC CLABSI Criteria</a>; <a href="./references#CD003295-bbs2-0056" title="MermelLA , FarrBM , SherertzRJ , RaadII , O'GradyN , Harris JS et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases2009;49:1-45.">Mermel 2009</a>; <a href="./references#CD003295-bbs2-0058" title="O'GradyNP , AlexanderM , DellingerEP , GerberdingJL , HeardSO , Maki DG et al. Guidelines for the prevention of intravascular catheter related infections. Pediatrics2002;110:51-75.">O'Grady 2002</a>). Some authors registered all bloodstream infections (BSI), defined as infection‐related symptoms and a positive blood culture. </p> </li> <li> <p>Local infections, i.e. exit‐site infections (positive exit site culture, cellulitis or pus around the exit site) or tunnel infections (cellulitis overlying the tunnel tract). </p> </li> </ul> </p> <p>If studies reported CRBSI/CLABSI and proxy outcomes, we preferentially used the CRBSI/CLABSI data in our meta‐analyses. </p> </section> <section id="CD003295-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p>We investigated adverse events related to the interventions.</p> </section> </section> </section> <section id="CD003295-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003295-sec-0024"> <h4 class="title">Electronic searches</h4> <p>The original review's search was run in July 2001 (Medline and Embase 1966 to 2000, and Central: Issue 4, 2000). We ran subsequent searches on 6 September 2006, 28 June 2013 and 17 September 2013. For this updated review, we searched the following databases on 19 November 2020: </p> <p> <ul id="CD003295-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 11), in the Cochrane Library; </p> </li> <li> <p>MEDLINE via Ovid (June 2013 to week 1 November 2020);</p> </li> <li> <p>Embase via Ovid (June 2013 to week 46 2020).</p> </li> </ul> </p> <p>The search strategies are outlined in <a href="./appendices#CD003295-sec-0068">Appendix 1</a>; <a href="./appendices#CD003295-sec-0069">Appendix 2</a>; and <a href="./appendices#CD003295-sec-0070">Appendix 3</a>. </p> </section> <section id="CD003295-sec-0025"> <h4 class="title">Searching other resources</h4> <p>For the initial review, we handsearched the following conference proceedings: International Society for Paediatric Oncology (SIOP) (1995 to 2005), Multinational Association of Supportive Care in Cancer (MASCC) (1995 to 2005), American Society of Clinical Oncology (ASCO) (1995 to 2005), Interscience Conference of Antimicrobial agents and Chemotherapy (ICAAC) (1995 to 2005). We did not obtain any extra information from the conference proceedings. For this updated review, we did not handsearch conference proceedings.  </p> <p>To identify any additional articles, we searched <a href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a> and the World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/clinical-trials-registry-platform" target="_blank">www.who.int/clinical-trials-registry-platform</a>). Additionally, we handsearched reference lists of included studies and other related publications.  </p> </section> </section> <section id="CD003295-sec-0026"> <h3 class="title" id="CD003295-sec-0026">Data collection and analysis</h3> <p>For this version of the review, we updated the methods. Please see <a href="#CD003295-sec-0078">Differences between protocol and review</a>. </p> <section id="CD003295-sec-0027"> <h4 class="title">Selection of studies</h4> <p>We independently identified and classified the eligible studies. For the first original review (published in Issue 3, 2003; updated version published in 2007), Marianne van der Wetering (MvdW) and Job van Woensel (JvW) performed this; Theresa Lawrie (TAL) and MvdW undertook this for the updated version of 2013. For this current update, MvdW and Ceder van den Bosch (CvdB) identified and classified the eligible studies.  </p> </section> <section id="CD003295-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We extracted data on to a predesigned data extraction and collection form (gram‐positive CVC‐related infection events and total number of participants/CVCs). In addition, we recorded the following information for each study, where possible: </p> <p> <ul id="CD003295-list-0005"> <li> <p>study location, accrual dates;</p> </li> <li> <p>participant inclusion and exclusion criteria;</p> </li> <li> <p>type of long‐term CVCs used, site, technique and timing of insertion;</p> </li> <li> <p>type of intervention(s), dose and timing of administration;</p> </li> <li> <p>methods of randomisation and allocation concealment;</p> </li> <li> <p>baseline characteristics of participants including age, type of cancer and previous chemotherapy; </p> </li> <li> <p>types of outcomes; and</p> </li> <li> <p>adverse events.</p> </li> </ul> </p> </section> <section id="CD003295-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the included studies using the Cochrane Risk of Bias version 1.0 tool (RoB 1) according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003295-bbs2-0048" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). As in the original review, we also assessed the methodological quality (quality of randomisation, blinding and analysis) according to the van Tulder criteria (<a href="./references#CD003295-bbs2-0071" title="vanTulderMW , AssendelftWJ , KoesBW , BouterLM . Method guidelines for systematic reviews in the Cochrane Collaboration Back review group for spinal disorders. Spine1997;22:2323-30.">van Tulder 1997</a>). We contacted the authors for additional information, where necessary, and resolved disagreements between review authors by discussion. </p> </section> <section id="CD003295-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>For the studies assessing the efficacy of prophylactic antibiotics prior to CVC insertion, dichotomous data were required. We presented these results as pooled risk ratios with 95% confidence intervals (CIs). We did not present these results as pooled rate ratios per 1000 CVC‐days because only one of the included studies reported CVC‐days. For studies assessing the efficacy of antibiotic flush/lock solutions, we used the generic inverse variance to calculate the pooled rate ratios per 1000 CVC‐days and their 95% CIs. </p> </section> <section id="CD003295-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>All review outcomes required randomisation at the level of CVCs or participants if only one CVC was inserted per person.  </p> </section> <section id="CD003295-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial authors in cases of missing data. If data were not available, we only analysed the available data.  </p> </section> <section id="CD003295-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the T², I² and Chi² statistics. We considered heterogeneity to be substantial if I² was 50% or more. </p> </section> <section id="CD003295-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>If no trial protocol was accessible or the outcomes described in the method section differed from the outcomes described in the result section, we suspected a high risk of reporting bias. Where 10 or more trials contributed to the meta‐analysis, we planned to visually assess the risk of publication bias using funnel plots.  </p> </section> <section id="CD003295-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We grouped the studies according to the interventions evaluated and analysed these groups separately, as follows: </p> <p> <ol id="CD003295-list-0006"> <li> <p>studies of intravenous antibiotic prophylaxis prior to insertion of the long‐term CVC versus placebo or no antibiotics; </p> </li> <li> <p>studies of antibiotic flush or lock solutions versus standard flush or lock solutions following long‐term CVC insertion. </p> </li> </ol> </p> <p>We pooled data in the meta‐analyses using <a href="./references#CD003295-bbs2-0060" title="Review Manager (RevMan). Version 5.4.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">RevMan 2020</a>. Where the results for CVC‐related infections also described gram‐negative infections, we included the gram‐positive data only. We used the random‐effects model for all meta‐analyses due to substantial heterogeneity between studies with regard to design, interventions and populations. </p> </section> <section id="CD003295-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses, where possible. Potential reasons for heterogeneity included the age of participants (adults versus children), antibiotic types (vancomycin versus others) and CVC types. </p> </section> <section id="CD003295-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses where there was a high risk of bias associated with the quality of one of the included studies.  </p> </section> <section id="CD003295-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We assessed the certainty of evidence using the GRADE approach (<a href="./references#CD003295-bbs2-0065" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>). This takes into account issues not only related to internal validity (risk of bias, inconsistency, imprecision, publication bias) but also to external validity such as directness of results (<a href="./references#CD003295-bbs2-0066" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020.. Available from training.cochrane.org/handbook.">Schünemann 2020</a>). We created a summary of findings table based on the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003295-bbs2-0049" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors).  Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook (accessed prior to 10 August 2021).">Higgins 2020</a>) and using the GRADEPro Guideline Development Tool (<a href="./references#CD003295-bbs2-0045" title="GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), accessed 21 September 2021. Available at gradepro.org.">GRADEpro GDT</a>). We used the GRADE checklist and GRADE Working Group certainty of evidence definitions (<a href="./references#CD003295-bbs2-0055" title="MeaderN , KingK , LlewellynA , NormanG , BrownJ , RodgersM , Moe-ByrneT , HigginsJP , SowdenA , StewartG . A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews2014;3:82.">Meader 2014</a>). For each study limitation we downgraded the evidence from 'high' certainty by one level for serious concerns, or by two levels for very serious concerns. We scored the certainty of evidence as very low, low, moderate or high. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003295-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003295-sec-0039"></div> <section id="CD003295-sec-0040"> <h3 class="title">Description of studies</h3> <p>We included 12 studies in total in this review; six evaluated the efficacy of antibiotic administration prior to central venous catheter (CVC) insertion, and six evaluated the efficacy of antibiotic lock/flush solutions for the prevention of CVC‐related infections (<a href="./references#CD003295-sec-0080" title="">Characteristics of included studies</a>). </p> <section id="CD003295-sec-0041"> <h4 class="title">Results of the search</h4> <p>In the original 2007 review (search from 1966 to 2006), we identified the abstracts of 40 potentially relevant studies and on screening excluded 20 of these. Of the remaining 20 studies, we classified 11 studies as excluded and nine as included. </p> <p>In the 2013 updated review (search from 2006 to 2013), we identified an additional 16 records for classification. Of these 16 records, we classified 11 studies (12 citations) as excluded and two (four citations) as included.  </p> <p>For the current updated review, we found 336 potentially relevant studies through database searches. After de‐duplication, 310 studies remained. After using the Cochrane RCT Classifier machine learning tool and title and abstract screening, we identified three potentially relevant records for classification. We excluded two records after full‐text screening due to the inclusion of only non‐tunnelled CVCs (<a href="./references#CD003295-bbs2-0025" title="GudiolC , ArnanM , Aguilar-GuisadoM , Royo-CebrecosC , Sanches-OrtegaI , MonteroI , et al. A randomized, double-blind, placebo-controlled trial (TAURCAT study) of citrate lock solution for prevention of endoluminal central venous catheter infection in neutropenic hematological patients. Antimicrobial Agents and Chemotherapy2020;64(2):e01521-19. ">Gudiol 2020</a>), and one ongoing study (<a href="./references#CD003295-bbs2-0038" title="vanden BoschCH , vande WeteringMD , WijnenMH . Central line-associated bloodstream infection prevention using TauroLock-Hep100 in pediatric oncology patients (CATERPILLAR). www.trialregister.nl/trial/6500 (first registered 7 September 2017). ">van den Bosch 2017</a>). We contacted the authors of one study to check if they included participants who did not have newly‐inserted CVCs.  The authors replied that participants with metastatic solid cancer (57% of all included participants) already had a CVC before inclusion, therefore we excluded this article (<a href="./references#CD003295-bbs2-0029" title="LongoR , LlorensM , GoetzC , PlatiniC , EidN , SelliesJ , et al. Taurolidine/citrate lock therapy for primary prevention of catheter-related infections in cancer patients: results of a prospective, randomized, phase IV trial (ATAPAC). Oncology2017;93(2):99-105. ">Longo 2017</a>). After searching the trial registries, we identified two potentially relevant studies; one was still ongoing (<a href="./references#CD003295-bbs2-0037" title="ChambrierC . Primary prevention of infections related to Chambers implantable catheter by a taurolodine lock in patients with cancer receiving parenteral nutrition. clinicaltrials.gov/ct2/show/NCT02255318 (first received 2 October 2014). ">Chambrier 2014</a>), and we included the other one after full‐text screening (<a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). We contacted the authors of the included <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a> study to check if children were included, but we did not receive a reply.  </p> <p>Thus, for this updated review we included one additional study. (<a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>; <a href="#CD003295-fig-0001">Figure 1</a>; <a href="./references#CD003295-sec-0080" title="">Characteristics of included studies</a> <a href="./references#CD003295-sec-0081" title="">Characteristics of excluded studies</a>; <a href="./references#CD003295-sec-0082" title="">Characteristics of ongoing studies</a>). </p> <div class="figure" id="CD003295-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Updated Search Flow Diagram" data-id="CD003295-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Updated Search Flow Diagram</p> </div> </div> </div> </section> <section id="CD003295-sec-0042"> <h4 class="title">Included studies</h4> <p>The 12 studies enrolled 1244 participants in total. Five studies were conducted in adults (N = 352) (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>; <a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a>; <a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>), four studies in children (N = 344) (<a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a>; <a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a>; <a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a>), two studies enrolled both (N = 144) (<a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>), and for one study (N = 404) it was not clear if children were also included in the trial (<a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). Nine trials included participants with solid tumours and haematological malignancies, two trials included participants with haematological malignancies only (<a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>), and one trial included participants with solid tumours only (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>). We only included studies observing newly‐inserted CVCs, except for the study by <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a>, which also enrolled an unspecified number of children with tunnelled central venous catheters (TCVCs) already in situ. Most studies evaluated infections in TCVCs, three studies used totally implantable devices (TIDs) (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). The <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a> study used both TCVCs and TIDs. </p> <p>Six studies evaluated the administration of antibiotics prior to central venous catheter (CVC) insertion. The antibiotics used in these studies were as follows: </p> <p> <ul id="CD003295-list-0007"> <li> <p>vancomycin (<a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a>; <a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>); </p> </li> <li> <p>teicoplanin (<a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>); </p> </li> <li> <p>ceftazidime (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>); </p> </li> <li> <p>cefazolin (<a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). </p> </li> </ul> </p> <p>Six studies evaluated flushing or locking the CVC with a combination of an antibiotic and heparin. Antibiotics used in these studies were as follows: </p> <p> <ul id="CD003295-list-0008"> <li> <p>vancomycin (<a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a>; <a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a>); </p> </li> <li> <p>vancomycin (+/‐ ciprofloxacin) (<a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a>); </p> </li> <li> <p>vancomycin and amikacin (<a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>); </p> </li> <li> <p>taurolidine (<a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>). </p> </li> </ul> </p> <p>Most studies evaluated and reported CVC‐related infections over the lifespan of the CVC. Four studies reported early CVC‐related infections, occurring within 21 to 30 days of insertion (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>; <a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a>). Seven studies reported a catheter related sepsis (CRS) completely or partially defined following the central line associated bloodstream infection (CLABSI) or catheter related bloodstream infection (CRBSI) criteria (<a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a>; <a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>; <a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a>; <a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a>; <a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>). A minority defined a CRS as a positive blood culture and clinical symptoms (<a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>), another study used a definition for CRS mainly depending on the response to treatment (<a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a>). Two studies reported local infections (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). </p> </section> <section id="CD003295-sec-0043"> <h4 class="title">Excluded studies</h4> <p>We excluded 26 studies for the following reasons (11 for the original review, 11 for the first updated review and 4 for the current updated review; see <a href="./references#CD003295-sec-0081" title="">Characteristics of excluded studies</a>). </p> <p> <ul id="CD003295-list-0009"> <li> <p>Participants were ill neonates and not people with cancer (two studies: <a href="./references#CD003295-bbs2-0024" title="GarlandJS , AlexCP , HenricksonKJ , McAuliffeTL , MakiDG . A vancomycin-heparin lock solution for the prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective randomized trial. Pediatrics2005;116:198-205. ">Garland 2005</a>; <a href="./references#CD003295-bbs2-0030" title="OceteE , Ruiz-ExtremeraA , GoicoecheaA , LozanoE , RoblesC , ReyML , et al. Low dosage prophylactic vancomycin in central venous catheters for neonates. Early Human Development1998;Suppl 53:S181-6. ">Ocete 1998</a>). </p> </li> <li> <p>Non‐tunnelled CVCs were used (seven studies: <a href="./references#CD003295-bbs2-0016" title="CarratalaJ , NiuboJ , Fernandez-SevillaA , JuveE , CastellsagueX , BerlangaJ , et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of Gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrobial Agents and Chemotherapy1999;43(9):2200-4. ">Carratala 1999</a>; <a href="./references#CD003295-bbs2-0019" title="ChatzinilolaouI , FinkelK , HannaH , BoktourM , ForingerJ , HoT , et al. Antibiotic coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective randomized study. American Journal of Medicine2003;115:352-7. ">Chatzinikolaou 2003b</a>; <a href="./references#CD003295-bbs2-0025" title="GudiolC , ArnanM , Aguilar-GuisadoM , Royo-CebrecosC , Sanches-OrtegaI , MonteroI , et al. A randomized, double-blind, placebo-controlled trial (TAURCAT study) of citrate lock solution for prevention of endoluminal central venous catheter infection in neutropenic hematological patients. Antimicrobial Agents and Chemotherapy2020;64(2):e01521-19. ">Gudiol 2020</a>; <a href="./references#CD003295-bbs2-0026" title="HannaH , BenjaminR , ChatzinikolaouI , AlakechB , RichardsonD , Mansfield P et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. Journal of Clinical Oncology2004;22(15):3163-71. ">Hanna 2004</a>; <a href="./references#CD003295-bbs2-0028" title="JaegerK , ZenzS , JuttnerB , RuschulteH , KuseE , HeineJ , et al. Reduction of catheter-related infections in neutropenic patients: A prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Annals of Hematology2005;84:258-62. ">Jaeger 2005</a>; <a href="./references#CD003295-bbs2-0031" title="RaadII , HachemRY , Abi-SaidD , RolstonKV , WhimbeyE , BuzaidAC , et al. A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin 2. Cancer1998;82(2):403-11. ">Raad 1998</a>; <a href="./references#CD003295-bbs2-0035" title="SchierholzJM , NagelschmidtK , NagelschmidtM , LeferingR , YucelN , BeuthJ . Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter. Anticancer Research2010;30:1353-8. ">Schierholz 2010</a>). </p> </li> <li> <p>Studies were not RCTs (seven studies: <a href="./references#CD003295-bbs2-0015" title="Al SibaiMB , HarderEJ , FaskinRW , JohnsonGW , PadmosMA . The value of prophylactic antibiotics during the insertion of long-term indwelling silastic right atrial catheters in cancer patients. Cancer1987;60:1891-5. ">Al Sibai 1987</a>; <a href="./references#CD003295-bbs2-0018" title="ChatzinikolaouI , ZipfT , HannaH , UmphreyJ , RobertsW , SheretzR , et al. Minocycline-ethylenediamine-tetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clinical Infectious Diseases2003;36:116-9. ">Chatzinikolaou 2003a</a>; <a href="./references#CD003295-bbs2-0020" title="DawsonS , FitzgeraldP , LangerJC , WaltonM , WinthropA , LauG , et al. A preoperative protocol for the prevention of infection in children with tunnelled right atrial catheters. Oncology Repertorium2000;7:1239-42. ">Dawson 2000</a>; <a href="./references#CD003295-bbs2-0023" title="FourcadeJ , MallavalFO , RaffenotD , MercierD , MaretJ , MorelB . Value of an antibiotic lock for the prevention of bacteraemia recurrence from central catheters in chronic hemodialysis. Nephrologie2001;22(8):457-8. ">Fourcade 2001</a>; <a href="./references#CD003295-bbs2-0033" title="RubieH , JuricicM , ClaeyssensS , KrimouA , LemozyJ , IzardP , et al. Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer. Archives of Diseases in Childhood1995;72:325-9. ">Rubie 1995</a>; <a href="./references#CD003295-bbs2-0034" title="ScaifeCL , GrossME , MoneMC , HansenHJ , LitzCL , NelsonET , et al. Antibiotic prophylaxis in the placement of totally implanted central venous access ports. The American Journal of Surgery2010;200:719-23. ">Scaife 2010</a>; <a href="./references#CD003295-bbs2-0036" title="SimonA , AmmannRA , WiszniewskyG , BodeU , FleischhackG , BesudenMM . Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infectious Diseases2008;8:102. ">Simon 2008</a>); </p> </li> <li> <p>RCT did not evaluate newly‐inserted CVCs (four studies: <a href="./references#CD003295-bbs2-0014" title="AkyuzC , KupeliS , Yagci-KupeliB , BuyukpamukcuM . Prophylactic taurolidine use in central venous catheters of pediatric cancer patients: A prospective randomized study from single center. In: Pediatric Blood and Cancer. Vol. 42nd Congress of the International Society of Pediatric Oncology, SIOP 2010, Boston, MA United States, 21 to 24 October. 2010. AkyuzC , KupeliS , Yagci-KupeliB , BuyukpamukcuM . Prophylactic taurolidine use in port catheters of pediatric cancer patients: a prospective randomised controlled study from single center. European Journal of Clinical and Medical Oncology submitted 2012 (authors' manuscript). ">Akyuz 2012</a>; <a href="./references#CD003295-bbs2-0021" title="DumichenMJ , SeegerK , LodeHN , KuhlJS , EbellW , DegenhardtP , et al. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. The Journal of Hospital Infection2012;80:304-9. ">Dumichen 2012</a>; <a href="./references#CD003295-bbs2-0022" title="Ferreira ChaconJM , Hato de AlmeidaE , deLourdes SimoesR , Lazzarin C OzorioV , AlvesBC , Mello de AndreaML , et al. Randomized study of minocycline and edetic acid as a locking solution for central line (port-a-cath) in children with cancer. Chemotherapy2011;57:285-91. ">Ferreira Chacon 2011</a>; <a href="./references#CD003295-bbs2-0029" title="LongoR , LlorensM , GoetzC , PlatiniC , EidN , SelliesJ , et al. Taurolidine/citrate lock therapy for primary prevention of catheter-related infections in cancer patients: results of a prospective, randomized, phase IV trial (ATAPAC). Oncology2017;93(2):99-105. ">Longo 2017</a>). </p> </li> <li> <p>RCT did not evaluate prophylactic antibiotics (four studies: <a href="./references#CD003295-bbs2-0013" title="AbdelkefiA , TorjmanL , LadebS , OthmanTB , AchourW , LakhalA , et al. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. Journal of Clinical Oncology2005;23:7864-70. ">Abdelkefi 2005</a>; <a href="./references#CD003295-bbs2-0017" title="ChambersST , SandersJ , PattonWN , GanlyP , BirchM , CrumpJA , et al. Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial. The Journal of Hospital Infection2005;61:53-61. ">Chambers 2005</a>; <a href="./references#CD003295-bbs2-0027" title="HitzF , KlingbielD , OmlinA , RinikerS , ZerzA , CernyT . Athrombogenic coating of long-term venous catheter for cancer patients: A prospective, randomised, double-blind trial. Annals of Hematology2012;91:613-20. ">Hitz 2012</a>; <a href="./references#CD003295-bbs2-0032" title="RaadI , DarouicheR , VazquezJ , LentnekA , HachemR , HannaH , et al. Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America2005;40:374-80. ">Raad 2005</a>); </p> </li> </ul> </p> </section> <section id="CD003295-sec-0044"> <h4 class="title">Ongoing studies</h4> <p>We identified two ongoing RCTs without preliminary results (<a href="./references#CD003295-bbs2-0037" title="ChambrierC . Primary prevention of infections related to Chambers implantable catheter by a taurolodine lock in patients with cancer receiving parenteral nutrition. clinicaltrials.gov/ct2/show/NCT02255318 (first received 2 October 2014). ">Chambrier 2014</a>; <a href="./references#CD003295-bbs2-0038" title="vanden BoschCH , vande WeteringMD , WijnenMH . Central line-associated bloodstream infection prevention using TauroLock-Hep100 in pediatric oncology patients (CATERPILLAR). www.trialregister.nl/trial/6500 (first registered 7 September 2017). ">van den Bosch 2017</a>; see <a href="./references#CD003295-sec-0082" title="">Characteristics of ongoing studies</a>). </p> </section> </section> <section id="CD003295-sec-0045"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD003295-sec-0046"> <h4 class="title">Methodology assessment following the van Tudler 1997 criteria</h4> <p>The methodology, evaluated following the <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003295.pub3/references#CD003295-bbs2-0052" target="_blank">van Tulder 1997</a> criteria, of the included studies was mostly of a reasonable quality. However, sample sizes were relatively small and ranged from 27 (<a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>) to 404 participants (<a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). All studies described the eligibility criteria sufficiently and included adults, children or both, who were at risk of neutropenia due to their disease or chemotherapy. Most studies excluded participants already receiving antibiotics, except those used orally for selective gut decontamination (that is, the use of oral antibiotics before a neutropenic episode is expected in which the potentially pathogenic aerobic organisms are eliminated without affecting the non‐pathogenic anaerobic organisms). All studies evaluated participants with newly‐inserted CVCs; however, <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> also included an unspecified number of participants with CVCs already in situ. In <a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>, randomisation was initially performed but all participants were later included in the experimental group; therefore we only used the first part of the study in our analyses. Further details regarding the methodological quality assessment can be found in the additional tables: <a href="#CD003295-tbl-0002">Table 1</a>, <a href="#CD003295-tbl-0003">Table 2</a> and <a href="#CD003295-tbl-0004">Table 3</a>. </p> <div class="table" id="CD003295-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Criteria for the assessment of methodological quality of included studies (van Tudler 1997)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Implementation</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Participant selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the eligibility criteria specified?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant inclusion/exclusion criteria must have been described appropriately according to the reviewer. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>b1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a method of randomisation applied?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A random (unpredictable) allocation must have been applied.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>b2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the treatment allocation concealed?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation should have been performed by an independent person not responsible for determining eligibility for inclusion. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>c</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the groups similar at baseline with regard to the most important prognostic indicators?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Groups must be similar at baseline with regard to at least three of the four prognostic indicators of age sex duration of symptoms and value of main outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Intervention</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>d1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the experimental intervention explicitly described?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate description of the experimental intervention so that treatment can be replicated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>d2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the control intervention explicitly described?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate description of the control intervention so that treatment can be replicated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>e</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were co‐interventions avoided or similar for all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Co‐interventions should either have been avoided in the trial design or be similar in the 2 groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>f</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the participant blinded for the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate information about blinding must have been provided.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Outcome measurement</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the outcome assessor blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate information about blinding must have been provided.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the outcome measures relevant?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least one of the following outcome measures must be included: catheter‐related sepsis, exit infections, tunnel infections and time to first infection. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>i</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were complications described?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Any adverse events should be noted.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>j</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the dropout loss to follow up described and acceptable?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included people who did not complete the follow up period or were not included in the analysis should be described; if the percentage of dropouts is less than 20% a '+' is scored. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>k</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a follow‐up measurement performed?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome assessment after randomisation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>l</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the timing of the outcome similar for all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of outcome assessment should have started from the moment of treatment allocation and be identical for all intervention groups and all important outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Statistics</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>m</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the sample size described for each group?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sample size should have been presented for each group at randomisation and for the most important outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did the analysis include an intention‐to‐treat analysis?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For all randomised people the most important moments of effect measurement should have been reported. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>o</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were point estimates and measures of variability presented for the primary outcome measures? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For continuous data mean, median, standard deviation with 95 % confidence interval should be presented. For nominal and ordinal outcomes the number of people to whom the outcome measure applies and the total number of people must be presented. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>All criteria were scored yes (+), no (‐) or do not know (?)</p> </div> </div> <div class="table" id="CD003295-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Internal validity scores for van Tudler 1997 methodological quality criteria (items b1, b2, c, e, f, g, j, l, n)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>b1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>b2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>c</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>e</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>f</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>g</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>j</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>l</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>yes (+), no (‐) or do not know (?)</p> </div> </div> <div class="table" id="CD003295-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">External validity scores for van Tudler 1997 methodological quality criteria (items a, d1, d2, h, i, k, m, o)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>a</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>d1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>d2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>h</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>i</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>k</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>m</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>o</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>yes (+), no (‐) or do not know (?)</p> </div> </div> </section> <section id="CD003295-sec-0047"> <h4 class="title">Risk of bias assessment using the Cochrane RoB 1 tool</h4> <p>Using the Cochrane RoB 1 tool, we deemed the overall risk of bias of the trials to be low. The trials mainly scored an unclear or high risk of bias since the methods of allocation and randomisation were not described, a non‐blinded study design was used, and since not all studies included all randomised participants in the final analyses. The details of the risk of bias assessment for each domain are described below and in the <a href="./references#CD003295-sec-0080" title="">Characteristics of included studies</a> table; a summary is provided in <a href="#CD003295-fig-0002">Figure 2</a> and  <a href="#CD003295-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD003295-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003295-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD003295-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph for overall judgements about each risk of bias item." data-id="CD003295-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph for overall judgements about each risk of bias item.</p> </div> </div> </div> </section> <section id="CD003295-sec-0048"> <h4 class="title">Allocation</h4> <p>Only three studies clearly described their method of randomisation (<a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>; <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). Seven studies did not specify their method of allocation concealment, so we assessed these as having an unclear risk of bias for this domain (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>; <a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a>; <a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a>; <a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>). </p> </section> <section id="CD003295-sec-0049"> <h4 class="title">Blinding</h4> <p>Six trials were open‐label studies, where neither the investigator nor the participant were blinded (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>; <a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a>; <a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>). We therefore judged these to have a high risk of bias for this domain. We judged the other six studies to have a low risk of bias (<a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>; <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>; <a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a>; <a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a>). </p> </section> <section id="CD003295-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>Three trials did not include all randomised participants in the analyses, so we considered them to have a high risk of attrition bias (<a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>; <a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a>). We did not observe any missing data in the other included studies, so gave them a low risk of bias for this domain.  </p> </section> <section id="CD003295-sec-0051"> <h4 class="title">Selective reporting</h4> <p>There was no suspicion of selective reporting in the included studies, since all studies reported the preplanned outcomes and described the outcomes in their method section. </p> </section> <section id="CD003295-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>In <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>, open randomisation was performed and the study was stopped after an interim analysis (N = 65) since the preset efficacy estimation could not be met. We considered this study to be at a high risk of bias and therefore performed sensitivity analyses with and without these data. We did not identify any other potential sources of bias in the remaining studies. </p> </section> </section> <section id="CD003295-sec-0053"> <h3 class="title" id="CD003295-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD003295-tbl-0001"><b>Summary of findings 1</b> Summary of findings table</a> </p> <p>We have included the key outcomes for both comparisons in <a href="./full#CD003295-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD003295-sec-0054"> <h4 class="title">Antibiotic administration prior to long‐term central venous catheter (CVC) insertion</h4> <p>We included six studies: two used vancomycin, two used teicoplanin, one used ceftazidime, and one used cefazolin prophylaxis versus a placebo or no antibiotic administration. All six studies were conducted in adults (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>; <a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a>; <a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>; <a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a>; <a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a>). One study, with 108 participants, did not observe any CVC‐related infection events in either group (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>); we could not include this study in the quantitative analysis since it was not possible to calculate a risk ratio for it. The impact of this study on the pooled risk ratio would presumably be minimal. There was no difference in the risk of CVC‐related infections between the prophylactic antibiotic and control groups for the other five studies (pooled risk ratio 0.67, CI 95% 0.32 to 1.43; control versus intervention group risk 10.4% versus 7.3%; P = 0.30, I² = 55%; 648 adults; moderate‐certainty evidence; <a href="./references#CD003295-fig-0004" title="">Analysis 1.1</a>). There were no differences between the antibiotic subgroups (test for subgroup differences P = 0.83). In the sensitivity analysis, we removed a study that was at a high risk of bias (<a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a>), which made little difference to the overall effect (pooled RR 0.52, 95% CI 0.24 to 1.12; P = 0.09, I² = 40%; 583 adults). None of the studies reported the occurrence of adverse events.  </p> </section> <section id="CD003295-sec-0055"> <h4 class="title">Antibiotic versus non‐antibiotic flush/lock solution</h4> <p>We included six studies in this meta‐analysis; most studies were performed in children (<a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>; <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a>; <a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a>; <a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a>). The majority of studies used a combined vancomycin and heparin solution; one study used a vancomycin, amikacin and heparin solution (<a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>), and another used a combined taurolidine and heparin solution (<a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>). One study, with 45 participants, did not observe any CRS events in the intervention group during 4.792 CVC‐days (i.e. the sum of days from the start until the end of follow‐up during which a CVC is in situ). We could not include this study in the quantitative analysis since it was not possible to calculate a risk ratio. Six CRS events in the comparator group were observed during 6.303 CVC days (<a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a>). The impact of this study on the pooled rate ratio would presumably be minimal.  </p> <p>A combined antibiotic and heparin solution was associated with fewer CRS events than a heparin‐only solution (pooled rate ratio 0.47, CI 95% 0.26 to 0.85; control versus intervention group risk ratio 0.66 versus 0.27 per 1000 CVC‐days; P = 0.01, I² = 0%; 443 participants; moderate‐certainty evidence; <a href="./references#CD003295-fig-0005" title="">Analysis 2.1</a>).  </p> <p>When we excluded the studies which enrolled both adults and children (<a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>), and restricted our analyses to children only (N = 355), the pooled rate ratio was similar to the overall result (pooled rate ratio 0.45, 95% CI 0.19 to 1.04). </p> <p><a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> included some participants with existing CVCs; we performed a sensitivity analysis by excluding this study from the analysis and the results remained largely the same as the overall finding (pooled rate ratio 0.52, 95% CI 0.27 to 0.97). </p> <p><a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a> reported that 8 out of 21 (vancomycin and heparin group) versus 7 out of 24 (heparin‐only group) participants experienced occlusions requiring urokinase; they reported no other adverse events. <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> observed the occurrence of 3.99 (heparin‐only group) versus 3.47 (heparin and vancomycin group) and 1.75 (heparin, vancomycin and ciprofloxacin) occlusions per 1000 CVC‐days (P = 0.37 and P &lt; 0.01, respectively); no other adverse events occurred. <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a> reported that the majority of participants in the taurolidine and citrate group described an unpleasant taste when the CVC was flushed. Other authors did not describe the possible occurrence of adverse events.  </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003295-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003295-sec-0056"></div> <section id="CD003295-sec-0057"> <h3 class="title" id="CD003295-sec-0057">Summary of main results</h3> <p>Administering antibiotics prior to the insertion of long‐term CVCs did not reduce the risk of subsequent CVC‐related infections. An antibiotic flush/lock solution combined with heparin, however, probably halved the risk of subsequent CVC‐related infections in people with cancer with long‐term CVCs. Only mild adverse events associated with prophylactic antibiotic administration were reported. The strength of this review is that it provides an up‐to‐date overview of the efficacy of antibiotic prophylaxis for the prevention of CVC‐related infections, a very serious and frequently observed problem in this vulnerable group. The certainty of the evidence was deemed moderate for both outcomes due to the limitations described in detail below.  (<a href="./full#CD003295-tbl-0001">summary of findings Table 1</a>) </p> </section> <section id="CD003295-sec-0058"> <h3 class="title" id="CD003295-sec-0058">Overall completeness and applicability of evidence</h3> <p>Clinical heterogeneity between the included studies was observed. In this review, we included studies that enrolled adults, children, or both. However, children and adults can differ greatly regarding their primary risk of CVC‐related infections due to several factors, e.g. CVC type inserted, CVC duration, intensity of chemotherapy (<a href="./references#CD003295-bbs2-0044" title="deJongeRC , PoldermanKH , GemkeRJ . Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatric Critical Care Medicine2005;6(3):329-39.">de Jonge 2005</a>). As the first meta‐analysis included studies comprising mainly adults (<a href="./references#CD003295-fig-0004" title="">Analysis 1.1</a>), it is possible that the results of this meta‐analysis are not generalisable to children. Similarly, the second meta‐analysis (<a href="./references#CD003295-fig-0005" title="">Analysis 2.1</a>) included studies that were mainly conducted in children. Therefore, it is possible that the associated evidence, which indicates a beneficial effect of antibiotic flush/lock solutions, may not be generalisable to adults. </p> <p>Furthermore, we included studies evaluating the risk of CVC‐related infections in TIDs and TCVCs. However, TIDs might be associated with a lower risk of CVC‐related infections. Unfortunately, we did not identify enough studies to perform subgroup analyses for these groups to draw separate conclusions about the efficacy of prophylactic antibiotic use in people with either a TID or TCVC. One included study evaluated both participants with either TCVCs or TIDs (<a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>), and two studies evaluated participants with TIDs only (<a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). In <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>, which comprised mainly TIDs, long‐term CVC‐related infection rates in the control group were comparable to those reported in the TCVC studies. However, no early CVC‐related infections occurred in the 108 participants who were included in the <a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a> study, and only three early gram‐positive CVC‐related infections occurred in the <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a> study's 404 participants. </p> <p>Moreover, different antibiotic types were used in the included studies. These antibiotics possibly differ in terms of their efficacy against gram‐positive CVC‐related infections. Most antibiotic types were only investigated by one or two studies, so it was not possible to perform proper subgroup analyses. Therefore, we were not able to conclude which antibiotic type might be the most appropriate for the prevention of gram‐positive bloodstream infections in people with cancer. </p> <p>The included studies authors' used different definitions for CRS. Some definitions included all positive blood cultures in participants with clinical symptoms of an infection (<a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a>). This might result in the inclusion of non‐CVC‐related infections, resulting in questionable applicability of the evidence. Moreover, although the risk of infections is considered to be highest during the first 45 to 100 days after placement (<a href="./references#CD003295-bbs2-0039" title="AbbasAA , FryerCJ , PaltielC , ChedidF , FelimbanSK , YousefAA , et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatric Blood and Cancer2004;42:325-31.">Abbas 2004</a>; <a href="./references#CD003295-bbs2-0061" title="SalzmanM , RubinL . Intravenous catheter-related infections. Advances in Pediatric Infectious Diseases1995;10:337-68.">Salzman 1995</a>), few of the included studies defined or evaluated early CVC‐related infections. </p> <p>It should be noted that baseline infection rates might differ between institutions and that these should always be assessed before the introduction of antibiotic prophylaxis. </p> </section> <section id="CD003295-sec-0059"> <h3 class="title" id="CD003295-sec-0059">Quality of the evidence</h3> <p>Overall, we consider the evidence for the administration of antibiotics prior to CVC insertion to be of moderate‐certainty. We downgraded the evidence due to the substantial high heterogeneity of the results (<a href="./references#CD003295-fig-0004" title="">Analysis 1.1</a>, caused by differences in the population (adults versus pediatrics, TIDs versus TCVCs), intervention (different antibiotic types, doses, frequency of administration), and outcome (CVC‐related infection definitions) observed (<a href="./full#CD003295-tbl-0001">summary of findings Table 1</a>). </p> <p>We consider the evidence for the use of antibiotic flush/lock solutions to be of moderate‐certainty. We downgraded the evidence due to clinical heterogeneity caused by the factors as described above. Unfortunately, adverse events were not described by the majority of the studies and clinical heterogeneity was suspected, resulting in the quality of the evidence being assessed as low with regard to the incidence of adverse events (<a href="./full#CD003295-tbl-0001">summary of findings Table 1</a>). </p> <p>We deemed the overall risk of bias for all the included studies to be low. However, the trials frequently scored an unclear or high risk of bias for two of the domains (allocation and blinding). The majority of the studies did not describe their allocation or randomisation method, or both, possibly explained by the inclusion of a large number of studies performed before the year 2000. Additionally, in a majority of the included studies, the outcome assessors were not blinded. A blinded study is preferred since the evaluation of the positive blood cultures (i.e. CVC‐related or related to another infection source) might be susceptible for bias if a non‐blinded study design was used.   </p> </section> <section id="CD003295-sec-0060"> <h3 class="title" id="CD003295-sec-0060">Potential biases in the review process</h3> <p>We attempted to reduce bias in this review by excluding studies in which long‐term CVCs were already in situ. CVCs that were in situ prior to enrolment were likely to be pre‐colonised with bacteria. Including such studies may have led to spurious findings, higher rates of CVC‐related infections, and would have introduced another variable by which to adjust the results. </p> <p>Some included studies reported culture‐negative, gram‐negative and gram‐positive CVC‐related infections (for example: <a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a>; <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a>; <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a>; <a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a>). In these instances, we only used the gram‐positive data. It must be noted that the antibiotic group in <a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a> and <a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> also experienced lower rates of gram‐negative CRS. Had we included these data, the rate ratio would probably have more strongly favoured the antibiotic group in <a href="./references#CD003295-fig-0005" title="">Analysis 2.1</a>.  </p> <p>Like <a href="./references#CD003295-bbs2-0069" title="SnaterseM , RugerW , ScholteOP , ReimerWJ , LucasC . Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. The Journal of Hospital Infection2010;75:1-11.">Snaterse 2010</a>, we did not differentiate between flush and lock solutions in our meta‐analyses as we considered them to have the same effect on the catheter lumen. Similarly, as also stated above, we combined the results of studies using various antibiotics with activity against gram‐positive organisms into one meta‐analysis. </p> </section> <section id="CD003295-sec-0061"> <h3 class="title" id="CD003295-sec-0061">Agreements and disagreements with other studies or reviews</h3> <p>The original review found weak evidence in favour of antibiotic flush or lock solutions and no evidence to support systemic antibiotics. There remains no demonstrable benefit from prophylactic intravenous antibiotics before long‐term CVC insertion. However, evidence from our updated meta‐analysis supports a beneficial effect of an antibiotic solution for flushing or locking long‐term CVCs. In a 2010 review, <a href="./references#CD003295-bbs2-0069" title="SnaterseM , RugerW , ScholteOP , ReimerWJ , LucasC . Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. The Journal of Hospital Infection2010;75:1-11.">Snaterse 2010</a> pointed out that the lack of specificity in the outcomes measured in many of the included studies may have led to an overestimation of the effect. Other reviews and meta‐analyses all support a possible beneficial effect of an antibiotic and heparin flush or lock solution but conclude that the evidence is weak (<a href="./references#CD003295-bbs2-0051" title="LiuY ,   ZhangAQ , CaoL , XiaHT , MaJJ . Taurolidine Lock Solutions for the Prevention ofCatheter-Related Bloodstream Infections: A SystematicReview and Meta-Analysis of Randomized ControlledTrials. PloS One2013;8:e79417.">Liu 2013</a>; <a href="./references#CD003295-bbs2-0052" title="LiuH ,  Liu H, Deng J,   ChenL , YuanL , WuY . Preventing Catheter-Related Bacteremiawith Taurolidine-Citrate Catheter Locks:A Systematic Review and Meta-Analysis. Blood purification2014;37:179-87.">Liu 2014</a>; <a href="./references#CD003295-bbs2-0057" title="NorrisLB ,  KablaouiF , Brilhart MK, Bookstaver PB. Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients. International Journal of Antimicrobial Agents2017;50:308-17.">Norris 2017</a>; <a href="./references#CD003295-bbs2-0070" title="SunY , WanG , LiangL . Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: a meta-analysis. PloS one2020;15:e0231110.">Sun 2020</a>). We agree that more evidence is needed. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003295-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/urn:x-wiley:14651858:media:CD003295:CD003295-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Updated Search Flow Diagram" data-id="CD003295-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_t/tCD003295-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Updated Search Flow Diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003295-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/urn:x-wiley:14651858:media:CD003295:CD003295-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003295-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_t/tCD003295-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003295-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/urn:x-wiley:14651858:media:CD003295:CD003295-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph for overall judgements about each risk of bias item." data-id="CD003295-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_t/tCD003295-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph for overall judgements about each risk of bias item.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003295-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/urn:x-wiley:14651858:media:CD003295:CD003295-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Antibiotics versus non‐antibiotics prior to long‐term CVC insertion, Outcome 1: CVC‐related infections" data-id="CD003295-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_t/tCD003295-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Antibiotics versus non‐antibiotics prior to long‐term CVC insertion, Outcome 1: CVC‐related infections </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/references#CD003295-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003295-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/urn:x-wiley:14651858:media:CD003295:CD003295-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Antibiotic versus non‐antibiotic flush/lock solutions, Outcome 1: CVC‐related infections" data-id="CD003295-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_t/tCD003295-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Antibiotic versus non‐antibiotic flush/lock solutions, Outcome 1: CVC‐related infections </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/references#CD003295-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/media/CDSR/CD003295/image_n/nCD003295-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003295-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Prophylactic antibiotics for the prevention of gram‐positive infections associated with long‐term central venous children receiving treatment for cancer </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults and children diagnosed with an oncologic disease with a newly‐inserted long‐term CVC who were at risk of neutropenia due to chemotherapy or disease<br/><b>Setting:</b> inpatient and outpatient<br/><b>Intervention:</b> prophylactic antibiotics (prior to long‐term CVC insertion or as lock/flush solutions)<br/><b>Comparison:</b> no antibiotic administration </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk control groups</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Absolute effect prophylactic antibiotics (95% CI)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Antibiotics prior to long‐term CVC insertion versus control: catheter‐related infections</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk ratio 0.67<br/>(0.32 to 1.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>648 (5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Data inconsistent across studies; I² = 55%; P = 0.30.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000 participants</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000 (30 to 164)<br/> participants  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Antibiotic versus heparin only lock/flush solution: catheter‐related infections</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rate ratio 0.47 (0.26 to 0.85)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>443<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Data consistent across included studies; I² = 0%; P = 0.01.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.66 per 1000 CVC‐days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.27 per 1000 (0.16 to 0.43) CVC‐days</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antibiotic versus heparin only lock/flush solution: adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300 (3 RCTs)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An unpleasant taste was described by the majority of the participants included in the taurolidine/citrate group by one study. One study reported a significant lower incidence of occlusions associated with the vancomycin/ciprofloxacin/heparin group compared to the heparin‐only group. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the assumed risk is the mean control group risk across studies. The absolute effect (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>CVC: c</b>entral venous catheter </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence by one level due to substantial heterogeneity between the sutdies ( I<sup>2</sup> &gt; 50% and confidence intervals were not overlapping).  </p> <p><sup>b</sup>We downgraded the evidence since the sample was clinically heterogeneous.  </p> <p><sup>c</sup>We downgraded the evidence due to imprecision since only a few studies described the incidence of adverse events.  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003295-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Criteria for the assessment of methodological quality of included studies (van Tudler 1997)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Item ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Implementation</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Participant selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the eligibility criteria specified?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant inclusion/exclusion criteria must have been described appropriately according to the reviewer. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>b1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a method of randomisation applied?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A random (unpredictable) allocation must have been applied.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>b2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the treatment allocation concealed?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation should have been performed by an independent person not responsible for determining eligibility for inclusion. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>c</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the groups similar at baseline with regard to the most important prognostic indicators?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Groups must be similar at baseline with regard to at least three of the four prognostic indicators of age sex duration of symptoms and value of main outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Intervention</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>d1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the experimental intervention explicitly described?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate description of the experimental intervention so that treatment can be replicated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>d2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the control intervention explicitly described?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate description of the control intervention so that treatment can be replicated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>e</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were co‐interventions avoided or similar for all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Co‐interventions should either have been avoided in the trial design or be similar in the 2 groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>f</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the participant blinded for the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate information about blinding must have been provided.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Outcome measurement</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the outcome assessor blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate information about blinding must have been provided.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the outcome measures relevant?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least one of the following outcome measures must be included: catheter‐related sepsis, exit infections, tunnel infections and time to first infection. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>i</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were complications described?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Any adverse events should be noted.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>j</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the dropout loss to follow up described and acceptable?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included people who did not complete the follow up period or were not included in the analysis should be described; if the percentage of dropouts is less than 20% a '+' is scored. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>k</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a follow‐up measurement performed?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome assessment after randomisation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>l</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the timing of the outcome similar for all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Timing of outcome assessment should have started from the moment of treatment allocation and be identical for all intervention groups and all important outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Statistics</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>m</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was the sample size described for each group?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sample size should have been presented for each group at randomisation and for the most important outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did the analysis include an intention‐to‐treat analysis?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For all randomised people the most important moments of effect measurement should have been reported. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>o</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were point estimates and measures of variability presented for the primary outcome measures? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For continuous data mean, median, standard deviation with 95 % confidence interval should be presented. For nominal and ordinal outcomes the number of people to whom the outcome measure applies and the total number of people must be presented. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>All criteria were scored yes (+), no (‐) or do not know (?)</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Criteria for the assessment of methodological quality of included studies (van Tudler 1997)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003295-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Internal validity scores for van Tudler 1997 methodological quality criteria (items b1, b2, c, e, f, g, j, l, n)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>b1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>b2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>c</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>e</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>f</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>g</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>j</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>l</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>yes (+), no (‐) or do not know (?)</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Internal validity scores for van Tudler 1997 methodological quality criteria (items b1, b2, c, e, f, g, j, l, n)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003295-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">External validity scores for van Tudler 1997 methodological quality criteria (items a, d1, d2, h, i, k, m, o)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>a</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>d1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>d2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>h</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>i</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>k</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>m</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>o</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0006" title="KaranlikH , KurulS , SaipP , UnalES , SenF , DisciR , et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single center prospective randomized trial. The American Journal of Surgery2011;202(1):10-5. ">Karanlik 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0012" title="VassilomaniakisM , PlatniotisG , KoumakisG . Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation1995;15:77-80. ">Vassilomaniakis 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0010" title="RansonMR , OppenheimBA , JacksonA , KamthanAG , ScarffeJH . Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection1990;15:95-102. ">Ranson 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0007" title="LimSH , SmithMP , MachinSJ , GoldstoneAH . A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology1993;Suppl 54:10-3. ">Lim 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0001" title="BarrigaFJ , VarasM , PotinM , SapunarF , RojoH , Martinez A et al. Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology1997;28:196-200. ">Barriga 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0009" title="RackoffWR , WeimanM , JakobowskiD , HirschlR , StallingsV , BilodeauJ , et al. A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics1995;127(1):147-51. ">Rackoff 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0011" title="SchwartzC , HenricksonK , RoghmannK , PowellK . Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology1990;8(9):1591-7. ">Schwartz 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0005" title="HenricksonKJ , AxtellRA , HooverSM , KuhnSM , PritchettJ , Kehl SC et al. Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology2000;18(6):1269-78. ">Henrickson 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0002" title="DaghistaniD , HornM , RodriguezZ , SchoenikeS , ToledanoS . Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology1996;26:405-8. ">Daghistani 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0008" title="LjungmanP , HagglundH , BjorkstrandB , LonnqvistB , RingdenO . Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer1997;5:485-8. ">Ljungman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0003" title="CarloI , ToroA , PulvirentiE , PalermoF , ScibiliaG , CordioS . Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surgical Oncology2011;20:20-5. ">Di Carlo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003295-bbs2-0004" title="HandrupMM , FuurstedK , FunchP , MollerJK , SchroderH . Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. APMIS2012;120:794-801. HandrupMM , MøllerJK , SchrøderH . Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood Cancer2013;60(8):1292-8. HandrupMM , MollerJK , SchroderH . Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin. In: Pediatric Blood and Cancer. Vol. Conference: 43rd Congress of the International Society of Paediatric Oncology, SIOP 2011, Auckland, New Zealand, 28 to 30 October. 2011. ">Handrup 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>yes (+), no (‐) or do not know (?)</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">External validity scores for van Tudler 1997 methodological quality criteria (items a, d1, d2, h, i, k, m, o)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/full#CD003295-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003295-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus non‐antibiotics prior to long‐term CVC insertion</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 CVC‐related infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>756</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.32, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Vancomycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.05, 3.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Teicoplanin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.23, 2.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Ceftazadime</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Cefazolin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.05, 5.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus non‐antibiotics prior to long‐term CVC insertion</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/references#CD003295-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003295-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antibiotic versus non‐antibiotic flush/lock solutions</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 CVC‐related infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.26, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Vancomycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.19, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Vancomycin (+/‐ ciprofloxacin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.06, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Vancomycin and amikacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.06, 16.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.4 Taurolidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.15, 1.15]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antibiotic versus non‐antibiotic flush/lock solutions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003295.pub4/references#CD003295-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003295.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003295-note-0016">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003295-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003295-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD003295-note-0011">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD003295-note-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD003295-note-0015">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD003295-note-0010">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD003295-note-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD003295-note-0009">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003295\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003295\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003295\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003295\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003295\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=VXKc2U6b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003295.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003295.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003295.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003295.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003295.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716418147"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003295.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716418151"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003295.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9f05eb8a9368',t:'MTc0MDcxNjQxOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 